Article in today's Wall Street Journal:

The FDA is calling for an updated boxed warning for a class of antibiotics that includes Bayer AG’s Cipro, as well as Johnson & Johnson’s Levaquin and their generic versions.
By THOMAS M. BURTON
Updated May 12, 2016 5:41 p.m. ET

WASHINGTON—The Food and Drug Administration said Thursday it will require heightened warnings about serious and sometimes disabling side effects from the commonly used class of antibiotics called fluoroquinolones.

That class of medications is mostly sold now as generic drugs. But well-known brand names include Bayer AG’s Cipro, generically called ciprofloxacin; and Johnson & Johnson’s Levaquin, or levofloxacin. The class of antibiotics has been marketed for about three decades.

** Copyright ©2016 Dow Jones & Company, Inc. All Rights Reserved**